1Yang WY, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[ J3. N Engl J Med,2010 ;362 (12) :1090-101.
2Lavery LA, Armstrong DG, Wunderlich RP, et al. Diabetic foot syndrome : evaluating the prevalence and incidence of foot pathology in Mexican A- mericans and non-Hispanic whites from a diabetes disease management cohort JJ. Diabetes Care ,2003 ;26(5 ) : 1435-8.
3Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes[ J. JAMA,2005 ;293 (2) :217-28.
4Shaw JE, Bouhon JM. The pathogenesis of diabetic foot problems [ J3. Di- abetes, 1997 ;46 ( suppl 2 ) : S58-S61.
5Elhadd TA, Kennedy G, McLaren M, et al. Elevated levels of the soluble E-selectin in diabetic patients with severe symptomatic peripheral arterial occlusive disease requiring angioplasty. A possible role in diabetic vascu- lar disease [ J 1. Int Angio1,2000 ; 19 (2) : 171-5.
6Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cyto- kines in diabetic nephropathy [ J 3. J Am Soc Nephrol, 2008 ; 19 ( 3 ) :433- 42.
7Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease [ J 3. Nature, 2006 ;444 ( 7121 ) : 875-80.
8Boulton AJ. The diabetic foot:from art to science. The 18th Camillo Golgi lecture[ J3. Diabetologia,2004 ;47 ( 8 ) : 1343-53.
9Mabilleau G, Petrova NL, Edmonds ME, et al. Increased osteoclastic ac- tivity in acute Charcot's osteoarthropathy:the role of receptor activator of nuclear factor-K[3 ligand [ J 3- Diabetologia, 2008 ; 51 ( 6 ) : 1035 -40.
10Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cyto- kines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes[ J3. Lancet ,2005 ;366 ( 9502 ) :2058-61.
